Manhattan Pharmaceuticals to Present Preliminary Phase I Obesity Drug Data at 2005 Annual Meeting of NAASO
October 14, 2005 08:27 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 14, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) will present preliminary Phase I results of its obesity drug candidate, Oleoyl-estrone (OE), an experimental, orally...
Manhattan Pharmaceuticals Shares to Trade on the American Stock Exchange
October 06, 2005 09:36 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 6, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) common shares are expected to begin trading on the American Stock Exchange tomorrow October 7 under the symbol...
Manhattan Pharmaceuticals to Present at ValueRich Small-cap Financial Expo
September 14, 2005 16:25 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Sept. 14, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc.'s (OTCBB:MHTT) president and chief executive officer, Douglas Abel, will present an overview of the company and its obesity...
Manhattan Pharmaceuticals Obesity Drug Safe in Phase Ia Study
September 07, 2005 12:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Sept. 7, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) said Oleoyl-estrone, its experimental obesity drug, was shown to be safe with no serious adverse events noted in a...
Manhattan Pharmaceuticals Hires Redington, Inc. to Expand Reach in U.S. Investment Community
September 01, 2005 10:02 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Sept. 1, 2005 (PRIMEZONE) -- In an effort to expand its reach and raise awareness in the U.S. investment community, Manhattan Pharmaceuticals, Inc (OTCBB:MHTT) said it retained Redington,...
Manhattan Pharmaceuticals to Present at Oppenheimer Diabetes Conference
August 31, 2005 11:27 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Aug. 31, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) announced that Douglas Abel, president and chief executive officer, will present an overview of the company and its...
Manhattan Pharmaceuticals Raises $11.9 Million in Private Placement
August 30, 2005 09:30 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Aug. 30, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) completed a private placement of common stock and warrants to institutional and accredited investors resulting in...